aTYR PHARMA (ATYR) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to -$5.6 million.
- aTYR PHARMA's Other Gross PP&E Adjustments rose 472.71% to -$5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.6 million, marking a year-over-year increase of 472.71%. This contributed to the annual value of $1.5 million for FY2024, which is 336.66% down from last year.
- Latest data reveals that aTYR PHARMA reported Other Gross PP&E Adjustments of -$5.6 million as of Q3 2025, which was up 472.71% from -$5.7 million recorded in Q2 2025.
- In the past 5 years, aTYR PHARMA's Other Gross PP&E Adjustments ranged from a high of $4.1 million in Q4 2021 and a low of -$7.1 million during Q2 2023
- In the last 5 years, aTYR PHARMA's Other Gross PP&E Adjustments had a median value of -$5.6 million in 2025 and averaged -$3.3 million.
- Over the last 5 years, aTYR PHARMA's Other Gross PP&E Adjustments had its largest YoY gain of 19981.31% in 2023, and its largest YoY loss of 76082.22% in 2023.
- Over the past 5 years, aTYR PHARMA's Other Gross PP&E Adjustments (Quarter) stood at $4.1 million in 2021, then crashed by 86.84% to $535000.0 in 2022, then skyrocketed by 199.81% to $1.6 million in 2023, then decreased by 3.37% to $1.5 million in 2024, then tumbled by 461.48% to -$5.6 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$5.6 million for Q3 2025, versus -$5.7 million for Q2 2025 and -$5.8 million for Q1 2025.